Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravitreal Aflibercept Injection (IAI) for Radiation Retinopathy Trial (ARRT)

NCT03085784 is registered in ClinicalTrials.gov with Amy C Schefler, MD as lead sponsor.

NCT NCT03085784
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03085784 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravitreal Aflibercept Injection (IAI) for Radiation Retinopathy Trial (ARRT)
Lead sponsor
Amy C Schefler, MD
Phase
Phase 2
Overall status
Unknown status
Start date
July 5, 2017
Completion date
October 31, 2021
Enrollment
40 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

radiation retinopathy